Willow Biosciences Targets C$3M Capital Raise
Company Announcements

Willow Biosciences Targets C$3M Capital Raise

Willow Biosciences Inc (TSE:WLLW) has released an update.

Willow Biosciences Inc. is set to raise up to C$3.0 million through a private placement of 30,000,000 units at C$0.10 each, with the proceeds aimed at advancing its biotechnology endeavors, including a partnership with Laurus Labs. The units come with one common share and a half warrant, allowing purchase of additional shares at C$0.13 for three years. This capital boost is expected to fund the company’s operations and product development well into the end of 2025.

For further insights into TSE:WLLW stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskWillow Biosciences Partners for Ingredient Development
TipRanks Canadian Auto-Generated NewsdeskWillow Biosciences Launches New Enzyme Development Program
TipRanks Canadian Auto-Generated NewsdeskWillow Biosciences Strikes Key Deal with Kalsec Inc.
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App